Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · IEX Real-Time Price · USD
32.36
+0.27 (0.84%)
At close: Jul 19, 2024, 4:00 PM
32.32
-0.04 (-0.12%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Collegium Pharmaceutical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for COLL stock have an average target of 40, with a low estimate of 37 and a high estimate of 44. The average target predicts an increase of 23.61% from the current stock price of 32.36.
Analyst Consensus: Buy
* Price targets were last updated on Jun 7, 2024.
Analyst Ratings
The average analyst rating for COLL stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $41 → $44 | Hold → Strong Buy | Upgrades | $41 → $44 | +35.97% | Jun 7, 2024 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $39 | Buy → Hold | Downgrades | $39 | +20.52% | May 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +23.61% | Apr 11, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $37 → $40 | Strong Buy | Maintains | $37 → $40 | +23.61% | Feb 26, 2024 |
Financial Forecast
Revenue This Year
595.35M
from 566.77M
Increased by 5.04%
Revenue Next Year
610.52M
from 595.35M
Increased by 2.55%
EPS This Year
6.38
from 1.29
Increased by 394.32%
EPS Next Year
7.21
from 6.38
Increased by 13.09%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 619.7M | 650.0M | 640.0M | 525.2M | 508.0M |
| Avg | 595.4M | 610.5M | 588.2M | 414.0M | 409.6M |
| Low | 568.9M | 568.0M | 514.0M | 336.3M | 344.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.3% | 9.2% | 4.8% | -10.7% | 22.7% |
| Avg | 5.0% | 2.5% | -3.7% | -29.6% | -1.1% |
| Low | 0.4% | -4.6% | -15.8% | -42.8% | -16.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 6.79 | 7.73 | 8.55 | 4.21 |
| Avg | 6.38 | 7.21 | 8.30 | 3.90 |
| Low | 5.98 | 6.46 | 7.98 | 3.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 426.6% | 21.2% | 18.5% | -49.3% |
| Avg | 394.3% | 13.1% | 15.1% | -53.0% |
| Low | 363.8% | 1.3% | 10.6% | -57.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.